OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 122 filers reported holding OCULAR THERAPEUTIX INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $8,920 | -18.8% | 2,000 | -42.9% | 0.01% | -25.0% |
| Q3 2023 | $10,990 | -39.1% | 3,500 | 0.0% | 0.01% | -38.5% |
| Q2 2023 | $18,060 | +100233.3% | 3,500 | 0.0% | 0.01% | -7.1% |
| Q1 2023 | $18 | +157.1% | 3,500 | +40.0% | 0.01% | +180.0% |
| Q4 2022 | $7 | -99.9% | 2,500 | 0.0% | 0.01% | -37.5% |
| Q3 2022 | $10,000 | 0.0% | 2,500 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $10,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |